What is the price-to-earnings ratio of Natera?
The price-earnings ratio of Natera is currently 10.99.
Natera P/S 2025
Natera P/S
10.99
Ticker
NTRA
ISIN
US6323071042
WKN
A14VPJ
As of Feb 4, 2025, Natera's P/S ratio stood at 10.99, a 48.11% change from the 7.42 P/S ratio recorded in the previous year.
The Natera P/S history
Natera Aktienanalyse
What does Natera do?
Natera Inc. is an American company headquartered in San Carlos, California. It was founded in 2004 by Matthew Rabinowitz and has been listed on the NASDAQ under the ticker symbol "NTRA" since 2015. The company is a leading provider of diagnostic tests and analyses and specializes in genetic analysis and diagnostic technologies. Natera specializes in tests for various medical areas, particularly in oncology diagnostics. The company's vision is to improve the quality of life for millions of people worldwide by offering innovative diagnostic tests to detect diseases early and ensure optimal treatment. Natera offers a wide range of products tailored to the needs of consumers, physicians, and scientists. The company operates in three business areas: 1) Women's Health: Natera offers tests for women and couples to determine the risk of hereditary diseases. For example, the company offers a test that allows analysis of fetal DNA from the mother's blood, allowing detection of genetic abnormalities in the fetus before birth. Additionally, Natera offers the Panorama test, which provides tests for genetic anomalies in unborn babies that can be used to determine the risk for chromosomal abnormalities and genetic mutations. 2) Oncology: In the field of oncology, Natera offers a wide range of diagnostic tests targeting developments and trends in cancer research. The tests aim to enable accurate diagnosis and prognosis, as well as provide individualized treatment for each patient. The company offers tests that assess the current tumor growth and metastatic potential, enable determination of tumor burden in cells, and provide tests for specific mutations required for determining optimal treatment. 3) Genomic Analysis: In the field of genomic analysis, Natera offers a broad range of tests available to researchers and scientists. This includes genetic variants and biological mechanisms that cause diseases. The company is also committed to developing its tests through artificial intelligence (AI) and machine learning. The goal is to provide more accurate and faster results, improve clinical decisions, and advance research and development of new diagnostics. Conclusion: Natera is a leading company in the field of diagnostic tests and analyses in the field of genomic analysis. The company has a long history of research and development of innovative product solutions for the medical community. One important focus of the company is to improve women's health and be able to detect risks for genetic diseases early; the other focus is on oncology diagnostic tools to determine optimal treatment for cancer patients. The company is constantly striving to further develop its tests and integrate new research findings and technologies to support the medical science community. Natera ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Natera's P/S Ratio
Natera's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Natera's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Natera's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Natera’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Natera stock
How has the price-earnings ratio of Natera changed compared to last year?
The price-to-earnings ratio of Natera has increased by 48.11% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Natera high compared to other companies?
Yes, the price-to-earnings ratio of Natera is high compared to other companies.
How does an increase in the price-earnings ratio of Natera affect the company?
An increase in the price-earnings ratio of Natera would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Natera affect the company?
A decrease in the price-earnings ratio of Natera would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Natera?
Some factors that influence the price-earnings ratio of Natera are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Natera pay?
Over the past 12 months, Natera paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Natera is expected to pay a dividend of 0 USD.
What is the dividend yield of Natera?
The current dividend yield of Natera is .
When does Natera pay dividends?
Natera pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Natera?
Natera paid dividends every year for the past 0 years.
What is the dividend of Natera?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Natera located?
Natera is assigned to the 'Health' sector.
Wann musste ich die Aktien von Natera kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Natera from 2/4/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 2/4/2025.
When did Natera pay the last dividend?
The last dividend was paid out on 2/4/2025.
What was the dividend of Natera in the year 2024?
In the year 2024, Natera distributed 0 USD as dividends.
In which currency does Natera pay out the dividend?
The dividends of Natera are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Natera
Our stock analysis for Natera Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Natera Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
